Systematic Assessment of Vascular Risk
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00378040|
Recruitment Status : Completed
First Posted : September 19, 2006
Last Update Posted : May 16, 2016
It is hypothesized that patients with vascular disease are undertreated for modifiable risk factors, leading to increased morbidity and mortality in this population.
The objective of this study is to develop a comprehensive database that will demonstrate the current adequacy of risk factor management in this high risk population, and that will provide needed guidance for future treatment options.
|Condition or disease|
|Peripheral Vascular Disease|
|Study Type :||Observational|
|Actual Enrollment :||800 participants|
|Official Title:||Toronto Vascular Disease Risk Factor Assessment Program: Systematic Assessment of Vascular Risk|
|Study Start Date :||June 2004|
|Primary Completion Date :||December 2006|
|Study Completion Date :||December 2015|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00378040
|Toronto General Hospital|
|Toronto, Ontario, Canada, M5G 2C4|
|Principal Investigator:||Thomas Lindsay, M.D||Toronto General Hospital, University Health Network|